{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:39:55Z","timestamp":1786653595760,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Human umbilical cord mesenchymal stem cells (hUC-MSCs) serve as a potential cell-based therapy for degenerative disease. They provide immunomodulatory and anti-inflammatory properties, multipotent differentiation potential and are harvested with no ethical concern. It is unknown whether MSCs collected from different areas of the human umbilical cord elicit more favorable effects than others. Three MSC populations were harvested from various regions of the human umbilical cord: cord lining (CL-MSCs), perivascular region (PV-MSCs), and Wharton's jelly (WJ-MSCs). Mesenchymal markers (CD90 and CD73) were expressed by all three cell populations. Stemness marker (OCT4), endothelial cell adhesion molecular marker (CD146), and monocyte-macrophage marker (CD14) were expressed by WJ-MSCs, PV-MSCs, and CL-MSCs, respectively. Stroke presents with oxygen and glucose deprivation and leads to dysfunctional mitochondria and consequently cell death. Targeting the restoration of mitochondrial function in the stroke brain through mitochondrial transfer may be effective in treating stroke.\n                      <jats:italic toggle=\"yes\">In vitro<\/jats:italic>\n                      exposure to ambient and OGD conditions resulted in CL-MSCs number decreasing the least post-OGD\/R exposure, and PV-MSCs exhibiting the greatest mitochondrial activity. All three hUC-MSC populations presented similar metabolic activity and survival in normal and pathologic environments. These characteristics indicate hUC-MSCs potential as a potent therapeutic in regenerative medicine.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/bc.bc_15_21","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T08:21:48Z","timestamp":1617092508000},"page":"33-36","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Mitochondrial activity of human umbilical cord mesenchymal stem cells"],"prefix":"10.4103","volume":"7","author":[{"given":"Blaise M.","family":"Cozene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Anzalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero La","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesario V.","family":"Borlongan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20240830","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: A report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"R2-8-20240830","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.redox.2018.03.002","article-title":"Diverse roles of mitochondria in ischemic stroke","volume":"16","author":"Yang","year":"2018","journal-title":"Redox Biol"},{"key":"R3-8-20240830","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/brainsci3020540","article-title":"Stroke neuroprotection: Targeting mitochondria","volume":"3","author":"Watts","year":"2013","journal-title":"Brain Sci"},{"key":"R4-8-20240830","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fnsys.2014.00116","article-title":"Stem cell-paved biobridge facilitates neural repair in traumatic brain injury","volume":"8","author":"Tajiri","year":"2014","journal-title":"Front Syst Neurosci"},{"key":"R5-8-20240830","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.biopha.2017.04.034","article-title":"Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders","volume":"91","author":"Caprnda","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"R6-8-20240830","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/2394-8108.186279","article-title":"Regeneration after stroke: Stem cell transplantation and trophic factors","volume":"2","author":"Chau","year":"2016","journal-title":"Brain Circ"},{"key":"R7-8-20240830","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/bc.bc_20_18","article-title":"Healthy mitochondria for stroke cells","volume":"4","author":"Russo","year":"2018","journal-title":"Brain Circ"},{"key":"R8-8-20240830","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/bc.bc_14_18","article-title":"Mitochondrial targeting as a novel therapy for stroke","volume":"4","author":"Russo","year":"2018","journal-title":"Brain Circ"},{"key":"R9-8-20240830","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.semcdb.2016.02.011","article-title":"Mitochondria in mesenchymal stem cell biology and cell therapy: From cellular differentiation to mitochondrial transfer","volume":"52","author":"Hsu","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"R10-8-20240830","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12929-018-0429-1","article-title":"Regenerative abilities of mesenchymal stem cells through mitochondrial transfer","volume":"25","author":"Paliwal","year":"2018","journal-title":"J Biomed Sci"},{"key":"R11-8-20240830","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/0271678X18811277","article-title":"May the force be with you: Transfer of healthy mitochondria from stem cells to stroke cells","volume":"39","author":"Borlongan","year":"2019","journal-title":"J Cereb Blood Flow Metab"},{"key":"R12-8-20240830","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/1574888X11308010012","article-title":"Human Wharton's jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: New perspectives for cellular therapy","volume":"8","author":"La Rocca","year":"2013","journal-title":"Curr Stem Cell Res Ther"},{"key":"R14-8-20240830","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/sctm.16-0492","article-title":"Concise review: Wharton's jelly: The rich, but enigmatic, source of mesenchymal stromal cells: Wharton's jelly an enigmatic msc source","volume":"6","author":"Davies","year":"2017","journal-title":"STEM CELLS Transl Med"},{"key":"R15-8-20240830","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s12015-020-09967-8","article-title":"Energy metabolism analysis of three different mesenchymal stem cell populations of umbilical cord under normal and pathologic conditions","volume":"16","author":"Russo","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"R16-8-20240830","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/ijms17020253","article-title":"Energy metabolism plays a critical role in stem cell maintenance and differentiation","volume":"17","author":"Hu","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R17-8-20240830","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1478-811X-8-18","article-title":"Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells","volume":"8","author":"Lavrentieva","year":"2010","journal-title":"Cell Commun Signal"},{"key":"R18-8-20240830","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jcyt.2018.01.001","article-title":"Quantitative analysis of composite umbilical cord tissue health using a standardized explant approach and an assay of metabolic activity","volume":"20","author":"Skiles","year":"2018","journal-title":"Cytotherapy"},{"key":"R19-8-20240830","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/1875043501104010006","article-title":"Phenotype and differentiation potential of stromal populations obtained from various zones of human umbilical cord: An overview","volume":"4","author":"Teresa Conconi","year":"2011","journal-title":"TOTERMJ"},{"key":"R20-8-20240830","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12015-017-9771-z","article-title":"New challenge: Mitochondrial epigenetics?","volume":"14","author":"Stimpfel","year":"2018","journal-title":"Stem Cell Rev Rep"},{"key":"R21-8-20240830","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12015-018-9809-x","article-title":"Dysfunction of mesenchymal stem cells isolated from metabolic syndrome and type 2 diabetic patients as result of oxidative stress and autophagy may limit their potential therapeutic use","volume":"14","author":"Kornicka","year":"2018","journal-title":"Stem Cell Rev Rep"},{"key":"R22-8-20240830","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/bc.bc_16_18","article-title":"Wharton' jelly mesenchymal stromal cell therapy for ischemic brain injury","volume":"4","author":"Wu","year":"2018","journal-title":"Brain Circ"},{"key":"R23-8-20240830","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12015-018-9855-4","article-title":"Metabolic syndrome modulates protein import into the mitochondria of porcine mesenchymal stem cells","volume":"15","author":"Aghajani Nargesi","year":"2019","journal-title":"Stem Cell Rev Rep"},{"key":"R24-8-20240830","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12015-019-09932-0","article-title":"Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders","volume":"16","author":"Al Naem","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"R25-8-20240830","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12015-019-09934-y","article-title":"Intracerebroventricular delivery of human umbilical cord mesenchymal stem cells as a promising therapy for repairing the spinal cord injury induced by kainic acid","volume":"16","author":"Nishida","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"R26-8-20240830","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12015-019-09914-2","article-title":"Comparison of the chondrogenic potential of mesenchymal stem cells derived from bone marrow and umbilical cord blood intended for cartilage tissue engineering","volume":"16","author":"Contentin","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"R27-8-20240830","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s12015-019-09907-1","article-title":"Wharton's jelly mesenchymal stromal cells from human umbilical cord: A close-up on immunomodulatory molecules featured in situ and in vitro","volume":"15","author":"Corsello","year":"2019","journal-title":"Stem Cell Rev and Rep"},{"key":"R28-8-20240830","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12015-019-09906-2","article-title":"A gutsy move for cell-based regenerative medicine in Parkinson's disease: Targeting the gut microbiome to sequester inflammation and neurotoxicity","volume":"15","author":"Lee","year":"2019","journal-title":"Stem Cell Rev and Rep"},{"key":"R29-8-20240830","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12015-019-09895-2","article-title":"Umbilical cord cell therapy improves spatial memory in aging rats","volume":"15","author":"Lehmann","year":"2019","journal-title":"Stem Cell Rev Rep"},{"key":"R30-8-20240830","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12015-019-9872-y","article-title":"Changes in stemness properties, differentiation potential, oxidative stress, senescence and mitochondrial function in Wharton's jelly stem cells of umbilical cords of mothers with gestational diabetes mellitus","volume":"15","author":"Kong","year":"2019","journal-title":"Stem Cell Rev Rep"},{"key":"R31-8-20240830","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00001756-200004070-00005","article-title":"Treatment with delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons","volume":"11","author":"Borlongan","year":"2000","journal-title":"Neuroreport"},{"key":"R32-8-20240830","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2217\/17460751.3.3.249","article-title":"Potential of stem\/progenitor cells in treating stroke: The missing steps in translating cell therapy from laboratory to clinic","volume":"3","author":"Borlongan","year":"2008","journal-title":"Regen Med"},{"key":"R33-8-20240830","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/01616412.1996.11740425","article-title":"CNS immunological modulation of neural graft rejection and survival","volume":"18","author":"Borlongan","year":"1996","journal-title":"Neurol Res"},{"key":"R34-8-20240830","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1089\/hum.2004.15.1243","article-title":"Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival","volume":"15","author":"Xia","year":"2004","journal-title":"Hum Gene Ther"},{"key":"R35-8-20240830","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0140-6736(99)90229-5","article-title":"Neural transplantation for neurodegenerative disorders","volume":"353","author":"Borlongan","year":"1999","journal-title":"Lancet"},{"key":"R36-8-20240830","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nbd.2006.04.014","article-title":"Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys","volume":"23","author":"Emerich","year":"2006","journal-title":"Neurobiol Dis"},{"key":"R37-8-20240830","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/exnr.1997.6493","article-title":"Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine \u2013 A immunosuppression","volume":"146","author":"Saporta","year":"1997","journal-title":"Exp Neurol"},{"key":"R38-8-20240830","doi-asserted-by":"crossref","first-page":"e90953","DOI":"10.1371\/journal.pone.0090953","article-title":"Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury","volume":"9","author":"Acosta","year":"2014","journal-title":"PLoS One"}],"container-title":["Brain Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_15_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:39:46Z","timestamp":1786649986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/bc.bc_15_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/bc.bc_15_21","relation":{},"ISSN":["2394-8108"],"issn-type":[{"value":"2394-8108","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}